|
|
Article: CARE assigns PR1+ to Dishman Pharmaceuticals' STD programme.
- Article from:
- ADP Debt News
- Article date:
- September 10, 2009
CopyrightCOPYRIGHT 2009 Aii Data Processing Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
(ADPnews) - Sep 10, 2009 - Indian Credit Analysis & Research said yesterday it assigned a rating of PR1+ to the short-term debt (STD) programme, including commercial paper (CP), of local Dishman Pharmaceuticals and Chemicals Ltd (BOM:532526).
The agency also confirmed at AA- the rating assigned to the company's long-term bank facilities and at PR1+ to the short-term bank facilities.
The ratings take into account Dishman Pharmaceuticals' experienced management, presence in the fast growing contract research and manufacturing services (CRAMS) segment of the pharmaceutical industry, API/intermediates manufacturing facilities which follow current good ...